SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹411 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr | ₹109 Cr |
What is the latest Consolidated Net Profit of SUVEN PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹411 Cr |
Mar2023 | ₹454 Cr |
Mar2022 | ₹362 Cr |
Mar2021 | ₹317 Cr |
Mar2020 | ₹109 Cr |
How is Consolidated Net Profit of SUVEN PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹411 Cr | -9.37 | |
Mar2023 | ₹454 Cr | 25.24 | |
Mar2022 | ₹362 Cr | 14.30 | |
Mar2021 | ₹317 Cr | 190.10 | |
Mar2020 | ₹109 Cr | - |
Compare Consolidated Net Profit of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹29,193.7 Cr | -7% | -2.3% | 77.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -7% |
-2.3% |
77.6% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses